Clear evidence for health technology assessment and health decision-making
CLEVIDENCE
What can you expect from us?
Let's work to achieve your goals. We will provide science-oriented services tailored to your expectations. Clevidence will speak for us.
Experienced professionals
Our team is made up of academics and professionals with experience both in scientific research and in the provision of services in the field of health economics and outcomes research, including health technology assessment and market access of medicinal products, as well as post-marketing research.
Tailored approach
Our services are designed in order to solve the problems posed by the client and to fulfill their objectives. The aim of our work is to reflect the best scientific evidence available on the subject under evaluation.
About Clevidence
Clevidence stands for clear evidence. There is no other way: health decisions must be made based on the best scientific evidence available.
Given the growing number of innovative therapeutic options in the context of finite health resources, decision makers have an increasing responsibility to make choices and select the most cost-effective interventions among the existing alternatives.
As such, rigorous, transparent, and methodologically sound assessments of the therapeutic, economic and social value of health technologies are crucial to inform health decision-making.
We use scientific research methods to generate, synthesise, analyse and assess the available evidence on the effects of health interventions.
Our aim is to deliver evidence-based assessments that can be used with confidence by health decision-makers and other stakeholders in healthcare, such as academia, clinicians, governments, hospitals and clinics, patients and pharmaceutical companies.
SERVICES
We have expertise and experience on carrying out services for market access, pricing and reimbursment of medicinal products and other health technologies, as well as on post-marketing research to assess the effects of health interventions in the real-world
-
![]()
Market access
BotãoWe provide solutions for market access, pricing and reimbursement of medicinal products, as well as other services based on health economics and outcomes research (HEOR)
-
![]()
Post-marketing research
BotãoGiven the limitations of clinical trials, post-marketing studies are essential to determine safety, efficacy, effectiveness and efficiency of medicinal products in routine clinical practice
-
![]()
Real-world evidence
BotãoDrug regulatory agencies and pharmaceutical companies are increasingly using real-world data (RWD) to assess outcomes of health interventions and to support clinical trials design
What can we do for you?
Market access
Market access, pricing and reimbursement
Strategy and evidence gap analysis
Health technology assessment (HTA)
- Systematic literature review
Clinical efficacy and safety
Use of healthcare resources
Health-related quality of life (HRQOL)
- Scoping review
- Epidemiology of disease
- Burden of illness
- Evidence-based value proposition (unmet need)
- Meta-analysis
- Network meta-analysis (NMA): indirect and mixed treatment comparison (ITC/MTC)
- Modelling for economic evaluation (cost-effectiveness, cost-utility, cost-benefit, cost-minimization)
- Budget impact analysis
- Value communication
Global value dossier (GVD)
Reimbursement dossier and HTA submission
Peer reviewed publication
Conference presentation
Post-marketing research
Post-authorisation safety studies (PASS)
Post-authorisation efficacy studies (PAES)
Effectiveness
Drug utilisation studies
Health Services Research
Patient-reported outcomes (PROs)
Health-related quality of life (HRQOL)
Real-world evidence
Observational studies
Electronic health records (EHRs)
Disease registries
Drug registries
How to contact us?
CLEVIDENCE
Taguspark
Av. Jacques Delors, Edifício Inovação II, 411-421
2740-122 Porto Salvo - Oeiras
Portugal
Institutional Support
Cofinanciado por:
